A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

NACompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

March 30, 2016

Primary Completion Date

April 18, 2018

Study Completion Date

April 18, 2018

Conditions
Primary Open Angle Glaucoma (POAG)
Interventions
DEVICE

CyPass Micro-Stent

The CyPass Micro-Stent is a small tube with a through-lumen designed to redirect aqueous fluid from the front into the back of the eye. The device is implanted after completion of cataract surgery.

PROCEDURE

Cataract Surgery

Cataract surgery involves the removal of the natural lens, which has become clouded (called a cataract), and insertion of an artificial lens (called an intraocular lens). This procedure is done through a small surgical incision in the eye.

Trial Locations (22)

15122

Alcon Investigative Site, West Mifflin

18704

Alcon Investigative Site, Kingston

33426

Alcon Investigative Site, Boynton Beach

33904

Alcon Investigative Site, Cape Coral

37232

Alcon Investigative Site, Nashville

37803

Alcon Investigative Site, Maryville

45242

Alcon Investigative Site, Cincinnati

51104

Alcon Investigative Site, Sioux City

63131

Alcon Investigative Site, St Louis

67846

Alcon Investigative Site, Garden City

72704

Alcon Investigative Site, Fayetteville

73104

Alcon Investigative Site, Oklahoma City

75231

Alcon Investigative Site, Dallas

76102

Alcon Investigative Site, Fort Worth

78229

Alcon Investigative Site, San Antonio

80134

Alcon Investigative Site, Parker

80525

Alcon Investigative Site, Fort Collins

85306

Alcon Investigative Site, Glendale

92037

Alcon Investigative Site, La Jolla

92868

Alcon Investigative Site, Orange

02111

Alcon Investigative Site, Boston

08361

Alcon Investigative Site, Vineland

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Transcend Medical, Inc.

INDUSTRY

lead

Alcon Research

INDUSTRY